ClinicalTrials.Veeva

Menu

Giessen Pulmonary Hypertension in Lung Cancer Registry (PHLHR)

U

University of Giessen

Status

Enrolling

Conditions

Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Treatments

Other: All lung cancer patients.

Study type

Observational

Funder types

Other

Identifiers

NCT04467333
PH in lung cancer registry

Details and patient eligibility

About

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with lung cancer at the University of Giessen lung Cancer Center.

Exclusion criteria

Trial design

500 participants in 1 patient group

All lung cancer patients
Description:
There will not be an intervention.
Treatment:
Other: All lung cancer patients.

Trial contacts and locations

1

Loading...

Central trial contact

Bastian Eul, MD; Michael John Cekay, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems